Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changtong oral liquid for prevention of postoperative abdominal adhesion after rectal cancer surgery
CTR20221964Phase 3Active
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Changtong Oral Liquid in Abdominal Adhesions, sponsored by Nanfang Hospital, Southern Medical University. Started Aug 2022; status: active.
02
Drugs
Changtong Oral Liquid
03
Conditions
Abdominal Adhesions
Beyond the preview
Go deeper on CTR20221964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221964.